BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23269996)

  • 1. Medical oncologists' perceptions of financial incentives in cancer care.
    Malin JL; Weeks JC; Potosky AL; Hornbrook MC; Keating NL
    J Clin Oncol; 2013 Feb; 31(5):530-5. PubMed ID: 23269996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are oncologists' financial incentives aligned with quality care?
    Wong YN
    J Clin Oncol; 2013 Feb; 31(5):517-9. PubMed ID: 23269998
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of financial incentives on medical practice: results from a systematic review of the literature and methodological issues.
    Chaix-Couturier C; Durand-Zaleski I; Jolly D; Durieux P
    Int J Qual Health Care; 2000 Apr; 12(2):133-42. PubMed ID: 10830670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient attitudes toward physician financial incentives.
    Pereira AG; Pearson SD
    Arch Intern Med; 2001 May; 161(10):1313-7. PubMed ID: 11371260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceived financial incentives, HMO market penetration, and physicians' practice styles and satisfaction.
    Hadley J; Mitchell JM; Sulmasy DP; Bloche MG
    Health Serv Res; 1999 Apr; 34(1 Pt 2):307-21. PubMed ID: 10199677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries.
    Adams JR; Elting LS; Lyman GH; George JN; Lembersky BC; Armitage JO; Demetri GD; Bennett CL
    Am J Med; 2004 Jan; 116(1):28-34. PubMed ID: 14706663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the effects of managed care on physicians' perceptions of their personal financial incentives.
    Mitchell JM; Hadley J; Sulmasy DP; Bloche JG
    Inquiry; 2000; 37(2):134-45. PubMed ID: 10985108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary care physicians' experience of financial incentives in managed-care systems.
    Grumbach K; Osmond D; Vranizan K; Jaffe D; Bindman AB
    N Engl J Med; 1998 Nov; 339(21):1516-21. PubMed ID: 9819451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance with quality prescribing indicators in terms of their relationship to financial incentives.
    Fernández Urrusuno R; Montero Balosa MC; Pérez Pérez P; Pascual de la Pisa B
    Eur J Clin Pharmacol; 2013 Oct; 69(10):1845-53. PubMed ID: 23743780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between a National Insurer's Pay-for-Performance Program for Oncology and Changes in Prescribing of Evidence-Based Cancer Drugs and Spending.
    Bekelman JE; Gupta A; Fishman E; Debono D; Fisch MJ; Liu Y; Sylwestrzak G; Barron J; Navathe AS
    J Clin Oncol; 2020 Dec; 38(34):4055-4063. PubMed ID: 33021865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing physician incentives for affordable, quality cancer care: results of an episode payment model.
    Newcomer LN; Gould B; Page RD; Donelan SA; Perkins M
    J Oncol Pract; 2014 Sep; 10(5):322-6. PubMed ID: 25006221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment.
    Rose JH; O'Toole EE; Dawson NV; Thomas C; Connors AF; Wenger N; Phillips RS; Hamel MB; Reding DT; Cohen HJ; Lynn J
    Med Care; 2000 Nov; 38(11):1103-18. PubMed ID: 11078051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial incentives and physicians' perceptions of conflict of interest and ability to arrange medically necessary services.
    Stoddard JJ; Reed M; Hadley J
    J Ambul Care Manage; 2003; 26(1):39-50. PubMed ID: 12545514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial incentives for quality in breast cancer care.
    Tisnado DM; Rose-Ash DE; Malin JL; Adams JL; Ganz PA; Kahn KL
    Am J Manag Care; 2008 Jul; 14(7):457-66. PubMed ID: 18611097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wellness activities address inequities.
    Dobson R; Lepnurm R
    Soc Sci Med; 2000 Jan; 50(1):107-21. PubMed ID: 10622698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician incentives and disclosure of payment methods to patients.
    Kao AC; Zaslavsky AM; Green DC; Koplan JP; Cleary PD
    J Gen Intern Med; 2001 Mar; 16(3):181-8. PubMed ID: 11318914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial incentives and physician prescription behavior: Evidence from dispensing regulations.
    Burkhard D; Schmid CPR; Wüthrich K
    Health Econ; 2019 Sep; 28(9):1114-1129. PubMed ID: 31264330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorting into payment schemes and medical treatment: A laboratory experiment.
    Brosig-Koch J; Kairies-Schwarz N; Kokot J
    Health Econ; 2017 Dec; 26 Suppl 3():52-65. PubMed ID: 29285865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Physician Peer Influence With Subsequent Physician Adoption and Use of Bevacizumab.
    Keating NL; O'Malley AJ; Onnela JP; Gray SW; Landon BE
    JAMA Netw Open; 2020 Jan; 3(1):e1918586. PubMed ID: 31899533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.
    Kurian AW; Bondarenko I; Jagsi R; Friese CR; McLeod MC; Hawley ST; Hamilton AS; Ward KC; Hofer TP; Katz SJ
    J Natl Cancer Inst; 2018 May; 110(5):493-500. PubMed ID: 29237009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.